UnitedHealth’s Optum is in talks to sell orthopedics and surgery services across New York, a potential shakeup for how specialty care and outpatient procedures get done in the city and its suburbs. The discussions were reported on June 23, 2026 and, if they actually lead to a deal, would mark a notable pullback after years of acquisitive growth in the tri-state market. Details on buyers, price and timing are still under wraps.
As reported by Crain's New York Business, the talks focus on orthopedics and outpatient surgery services tied to Optum’s regional physician platforms. Crain’s notes that negotiations are still at an early stage and that no formal agreement has been announced. A UnitedHealth spokesperson did not immediately respond to requests for comment for this article.
Which Assets Are Affected
Industry watchers and lawmakers are zeroing in on Optum Tri-State, the regional platform created after Optum bought large groups including CareMount, ProHEALTH and Crystal Run, as the most likely home of the surgical and orthopedic lines on the table, according to STAT. That consolidation of major New York-area physician groups has already drawn scrutiny from local elected officials and patient advocates.
Why Optum May Be Selling
UnitedHealth has been reshaping parts of Optum’s portfolio in a tougher operating environment, and its SEC filings point to realignments and gains tied to business disposals. UnitedHealth’s March 31, 2026 quarterly filing describes recent business realignments and notes gains on sales, a pattern analysts say can help shore up cash and simplify operations, according to UnitedHealth’s 10-Q.
What It Means for Patients and Staff
Any sale of specialty and surgery lines could mean new referral patterns, different insurance network setups and scheduling changes for patients who rely on those practices, providers say. Optum has previously shifted staff and closed or sold facilities in New York when it retooled parts of the business, and state filings and local reporting cited layoffs tied to a “sale of business” in recent years, according to Becker's Hospital Review.
Buyers to Watch
Potential suitors include hospital systems that want more outpatient capacity and private equity platforms that have been active in ambulatory surgery center deals. Research indicates that prices can climb after surgery centers change hands, a trend that will factor into how regulators and would-be buyers value these assets, per reporting from Healthcare Dive.
Regulatory and Legal Angle
The potential sale comes as UnitedHealth and Optum face heightened oversight from lawmakers and regulators over vertical integration and billing practices. That scrutiny, including congressional and state attention to changes at large Optum-owned physician groups, could influence not only whether a deal closes but also any conditions attached to it, as earlier inquiries have shown, according to STAT.
For now, the conversations are described as exploratory and no agreement has been announced. We reached out to Optum and UnitedHealth for comment; neither had provided a statement by the time of publication.
